David Fl Liew

29PUBLICATIONS
184CO-AUTHORS
Haematological tumoursRadiation therapyAllergyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 10, 2026
A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma.

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|Dec 05, 2025
Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic 18F-FDG PET/CT findings.

Emily Martin, Christopher R McMaster, Aurora Mt Poon

|Nov 13, 2025
Radioligand Therapy in Cancer Management: A Global Perspective.

Gaia Ninatti, Sze Ting Lee, Andrew M Scott

|Oct 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models.

Xin Du, Pei K Goh, Chenkai Ma

|May 13, 2025
Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Sagun Parakh, Nhi Huynh, Diana Dong Cao

Pageof 5

Frequent Collaborators

8 joint publications

Sze-Ting Lee

6 joint publications

Hui Kong Gan

4 joint publications

Christian Werner Wichmann

4 joint publications

John O Prior